Pharma.exp
💊 أكاديمية عملية لطلاب الصيدلة والصيادلة الجدد OTC عملي💢 💢 الحالات الجلدية 💢 التعامل داخل الصيدلية 💢 أشهر الأدوية والبدائل متابعة مستمرة بعد الكورس أكثر من 2500 طالب تم تدريبهم بكورساتنا د. محمد سعيد
Show more📈 Analytical overview of Telegram channel Pharma.exp
Channel Pharma.exp (@pharmaexp) in the Arabic language segment is an active participant. Currently, the community unites 12 138 subscribers, ranking 2 195 in the Medicine category and 6 358 in the Saudi Arabia region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 12 138 subscribers.
According to the latest data from 14 June, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 36 over the last 30 days and by -3 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 15.16%. Within the first 24 hours after publication, content typically collects 4.36% reactions from the total number of subscribers.
- Post reach: On average, each post receives 1 841 views. Within the first day, a publication typically gains 529 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 18.
- Thematic interests: Content is focused on key topics such as حَالَة, عِلَاج, مَرِيض, اِلتِهَاب, دَوَاء.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“💊 أكاديمية عملية لطلاب الصيدلة والصيادلة الجدد
OTC عملي💢
💢 الحالات الجلدية
💢 التعامل داخل الصيدلية
💢 أشهر الأدوية والبدائل
متابعة مستمرة بعد الكورس
أكثر من 2500 طالب تم تدريبهم بكورساتنا
د. محمد ...”
Thanks to the high frequency of updates (latest data received on 15 June, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
Available now! Telegram Research 2025 — the year's key insights 
